HomeOpen Access NewsDrug Development

Drug Development

Understanding the true impact of chronic pain

Chronic pain can affect a person’s life in a myriad of ways. Asal Shirazi BEM, Founder of the Autoimmune Support & Awareness Foundation (ASA Foundation), talks us through some of the conditions associated with chronic pain and the advancements in pain management.

EUMCA: Medical cannabis and research collaboration after Brexit

Here, we talk to Professor Trevor Jones at the European Medical Cannabis Association (EUMCA) about storing CBD, clinical trials post-Brexit and the UK-US trade deal.

Antimicrobial resistance: The next big pandemic?

Josep Figueras and Anna Sagan from the European Observatory on Health Systems and Policies focus here on antimicrobial resistance and ponder whether or not this could be the next big pandemic.

Ensuring a high and reproducible quality of medicinal cannabis

Renata Mala, PharmD, Chairman of Purely Plant GmbH, underlines the importance of ensuring high and reproducible quality when it comes to medicinal cannabis.

COVID-19 and pulmonary fibrosis

Steve Jones, President of EU-IPFF and Chair, Action for Pulmonary Fibrosis in the UK describes the connection between COVID-19 and pulmonary fibrosis.

New drug offers promising treatment for pancreatic cancer patients

Scientists have invented a new drug which could improve life expectancy and quality for patients with hard-to-treat cancers, such as pancreatic cancer.

Finding new antibiotics: The genome way

Professor Tilmann Weber discusses how microbial genomics helps to find the next generation of antibiotics in the race against antimicrobial resistance.

Cambridge COVID-19 vaccine gets £1.9 million to start trials

The University of Cambridge are developing a COVID-19 vaccine, which is expected to start clinical trials in Autumn 2020.

Nightingale hospitals could increase antibiotic resistance

The University of Plymouth revealed that secondary COVID-19 treatment could be increasing antibiotic resistance and polluting water.

New cell injection technique could reverse vision loss

Researchers at the University of Toronto Engineering tried co-injection of both retinal pigmented epithelium (RPE) cells and photoreceptor cells to reverse vision loss.

Male bias in drug development trials creates overmedication

New research shows that the gender gap in drug development trials results in an overmedication of women by healthcare professionals.

21 drugs that could help to treat COVID-19

A study recently identified 21 existing drugs that could improve the effect of remdesivir.

Genetic variant acts as a natural epidural, relieving pain in childbirth

Scientists at the University of Cambridge have discovered a genetic variant that acts as a natural epidural, explaining why some women do not need pain relief during childbirth.

Blood iron levels could be the reason behind slow ageing

Scientists from the University of Edinburgh and Max Planck Institute for Biology of Ageing identify blood iron levels as an ageing factor.

Can nanoparticles change lung cancer treatment?

A promising idea for lung cancer treatment has been developed by researchers at Lund University.

New research says remdesivir could be used to treat COVID-19

There is more positive news regarding remdesivir, the investigational anti-viral drug that has shown early promise in the fight against COVID-19.

EIB provide CureVac with €75m financing to fight infectious diseases

EIB and CureVac have signed a €75m loan agreement to develop a large-scale production of vaccines, including CureVac's vaccine candidate against SARS-CoV-2.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders